Publication Name	World Journal of Diabetes
Manuscript ID	10854
Country	United States

Received	2014-04-24 09:23
Peer-Review Started	2014-04-29 09:54
To Make the First Decision	2014-06-27 12:04
Return for Revision	2014-07-03 18:35
Revised	2014-07-09 02:31
Second Decision	2014-11-10 15:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-11-10 16:17
Articles in Press	2014-11-10 16:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-11-22 18:05
Publish the Manuscript Online	2014-12-13 19:01

ISSN	1948-9358 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Randomized Controlled Trial
Article Title	Pancreas transplantation: The Wake Forest experience in the new millennium
Manuscript Source	Invited Manuscript
All Author List	Jeffrey Rogers, Alan C Farney, Giuseppe Orlando, Samy S Iskandar, William Doares, Michael D Gautreaux, Scott Kaczmorski, Amber Reeves-Daniel, Amudha Palanisamy and Robert J Stratta
Funding Agency and Grant Number
Corresponding Author	Robert J Stratta, MD, Department of General Surgery, Wake Forest Baptist Medical Center, Medical Center Blvd., Winston Salem, NC 27157, United States. rstratta@wakehealth.edu
Key Words	Alemtuzumab; Mycophenolate mofetil; Pancreas transplantation; Portal-enteric; Rabbit anti-thymocyte globulin; Simultaneous kidney-pancreas transplantation; Solitary pancreas transplantation; Steroid elimination; Surveillance biopsy; Tacrolimus
Core Tip	Vascularized pancreas transplantation is able to establish a chronic insulin-free state characterized by normoglycemia. In selected recipients with insulin-requiring diabetes, simultaneous kidney-pancreas transplantation has become acknowledged as a favored alternative to kidney alone transplantation because of more intense glucose control, enhanced quality of life and improved long-term survival. The evolution in surgical technique, current patient management strategies, and biopsy directed immunosuppression have resulted in excellent outcomes, even in populations previously considered high risk, such as African-American recipients, patients with a “type 2 diabetes” phenotype and solitary pancreas transplants recipients.
Publish Date	2014-12-13 19:01
Citation	Rogers J, Farney AC, Orlando G, Iskandar SS, Doares W, Gautreaux MD, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Stratta RJ. Pancreas transplantation: The Wake Forest experience in the new millennium. World J Diabetes 2014; 5(6): 951-961
URL	http://www.wjgnet.com/1948-9358/full/v5/i6/951.htm
DOI	http://dx.doi.org/10.4239/wjd.v5.i6.951

Full Article (PDF)	WJD-5-951.pdf
Full Article (Word)	WJD-5-951.doc
Manuscript File	10854-Review.doc
Answering Reviewers	10854-Answering reviewers.pdf
Copyright License Agreement	10854-Copyright assignment.pdf
Peer-review Report	10854-Peer review(s).pdf
Scientific Misconduct Check	10854-CrossCheck.jpg
Scientific Editor Work List	10854-Scientific editor work list.pdf